Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
36,665,910
-
Share change
-
-2,038,227
-
Total reported value
-
$110,363,364
-
Put/Call ratio
-
128%
-
Price per share
-
$3.01
-
Number of holders
-
76
-
Value change
-
-$9,181,296
-
Number of buys
-
32
-
Number of sells
-
46
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2021
As of 31 Mar 2021,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,665,910 shares.
The largest 10 holders included
BVF INC/IL, NEA Management Company, LLC, BlackRock Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, Nuveen Asset Management, LLC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.